Study sees limited risk in taking ondansetron during first trimester of pregnancy
A new study from Brigham and Women’s Hospital finds that pregnant women taking the common anti-nausea medication ondansetron during the first trimester have no increased risk of cardiac malformations and only a slight increased risk of oral clefts.
Haley Bridger
• harvard
Dec. 18, 2018 • ~4 min
Dec. 18, 2018 • ~4 min
/
1